Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-051923

Director sold 8,994 shares at $21.91 ($197,059)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Vakiener Victoria Director 2024-12-16 Sale 10b5-1 −8,994 $21.91 $197,059 21,211 D
Open-market sales · 8,994 sh · avg $21.91 · $197,059
Loading xslF345X05/wk-form4_1734563707.xml…